Detalhe da pesquisa
1.
Neoadjuvant and adjuvant therapy for biliary tract cancer: Advances and limitations.
Hepatology
; 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38266282
2.
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients.
Int J Cancer
; 154(10): 1794-1801, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38312102
3.
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers.
Hepatology
; 78(3): 758-770, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999533
4.
Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(6): 653-677, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308125
5.
Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance.
Cancer Metastasis Rev
; 40(3): 837-862, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34591243
6.
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017.
Oncologist
; 27(10): 874-883, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35972334
7.
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(10): 1139-1167, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240850
8.
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study.
Lancet Oncol
; 22(9): 1290-1300, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34339623
9.
Development, Practice Patterns, and Early Clinical Outcomes of a Multidisciplinary Liver Cancer Clinic.
Cancer Control
; 28: 10732748211009945, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882707
10.
Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future.
Lancet Oncol
; 21(3): e135-e145, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32135117
11.
Spirituality in cancer patients on phase 1 clinical trials.
Psychooncology
; 29(6): 1077-1083, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32227382
12.
Cost-utility of colorectal cancer screening at 40â¯years old for average-risk patients.
Prev Med
; 133: 106003, 2020 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32001308
13.
A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors.
Cancer
; 125(16): 2837-2845, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31012962
14.
Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.
Invest New Drugs
; 37(2): 315-322, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30191522
15.
Readmission Adversely Affects Survival in Surgical Rectal Cancer Patients.
World J Surg
; 43(10): 2506-2517, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31222644
16.
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
N Engl J Med
; 372(26): 2509-20, 2015 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26028255
17.
Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.
Invest New Drugs
; 36(6): 1158, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334109
18.
Correction to: Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance.
Cancer Metastasis Rev
; 40(3): 863-864, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34668116
19.
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.
Br J Cancer
; 116(11): 1402-1407, 2017 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28441383
20.
Academic Cancer Center Phase I Program Development.
Oncologist
; 22(4): 369-374, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28314841